Publications
Lumify app banner image

Our vision for cancer care

Delivering innovation that matters to you

Across the world cancer is a dual threat. Cancer presents a health risk to more and more people. In fact, one out of two men and one out of three women are going to be diagnosed with cancer in their lifetime. Cancer is also an economic drain. The economic toll from cancer is nearly 20% higher than heart disease, the second leading cause of economic loss (€662 billion and €557 billion respectively). At Philips we are looking beyond technology to the experiences of the people at the heart of cancer care to unlock insights that are shaping the future of cancer care.

We are dedicated to helping you address your challenges through the creation of meaningful innovations

 

Gene Saragnese, CEO Philips Healthcare Imaging Systems says, “At EANM 2014, we were pleased to introduce Hot Spot, our new oncology magazine that is designed to share the latest trends, breakthroughs, and best practices in this exciting field with clinical caregivers and hospital managers. This magazine supports our broader healthcare ambition. At Philips we strive to make the world healthier and more sustainable through innovation. Our goal is to improve the lives of 3 billion people a year by 2025. It’s a truly global vision.”

Gene Saragnese LM

Our vision for future cancer care

“There’s an explosion of new insights into the root causes of cancer diseases,” says Saragnese. “One result is that we are now moving from “one size fits all” diagnostics and treatment to personalized and precise diagnostics and treatment, based on each individual’s personal situation. Major advancements in imaging are improving your ability to definitively diagnose that disease, to see smaller nodules, and get better clinical information so you can move rapidly toward a treatment plan. In the same way, we can now track the information over time to get a picture of what treatment is working and what needs to be adjusted.

 

These insights are also leading to new and more effective treatment options. We now have access to vital genomic insights that we can combine with pathology and imaging data, and other patient data. This is an opportunity, but it also creates an enormous information challenge to bring it all together.”

 

Philips oncology solutions cover the entire care continuum: from digital pathology solutions, image-guided biopsies, advanced imaging and treatment planning to image-guided oncology interventions. From patient monitoring and enterprise informatics platforms to home healthcare. We bring all of this together and center it around patients. Sometimes our solutions focus on general oncology or tumor tracking. Sometimes they focus on just a particular disease. But the particular needs of people are at the center of everything we do. Patients, caregivers, hospital managers.

infographicLMS image

Join us on the path to the future

 

Saragnese concludes, “As a customer you can count on our long-term view to help you stay state-of-the-art. You can tap into innovations, inventions, and long-range visions fresh from Philips Research. We are passionate about helping you provide cancer care that’s personalized for the particular needs of your patients; care that is as non-invasive and effective as possible.”

 

“We hope you enjoy the topics in this and coming magazines and value your feedback.”

For more information

 

For more information, go to our oncology website

Written by:

Gene Saragnese1 head

Gene Saragnese
CEO Philips Healthcare Imaging Systems

Share this article

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

You are entering a Philips Healthcare Australia website
Please select the checkbox

The information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).

By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.